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Corneal Replication Is an Interferon Response-Independent Bottleneck
for Virulence of Herpes Simplex Virus 1 in the Absence of Virion
Host Shutoff
Tracy Jo Pasieka,a Vineet D. Menachery,a,b Pamela C. Rosato,c and David A. Leibc
Department of Ophthalmology and Visual Sciencesa and Program in Immunology,b Washington University School of Medicine, St. Louis, Missouri, USA, and Department
of Microbiology and Immunology, Dartmouth Medical School, Lebanon, New Hampshire, USAc

Herpes simplex viruses lacking the virion host shutoff function (⌬vhs) are avirulent and hypersensitive to type I and type II interferon (IFN). In this study, we demonstrate that even in the absence of IFN responses in AG129 (IFN-␣␤␥Rⴚ/ⴚ) mice, ⌬vhs
remains highly attenuated via corneal infection but is fully virulent via intracranial infection. The data demonstrate that the interferon-independent inherent replication defect of ⌬vhs has a significant impact upon peripheral replication and
neuroinvasion.

H

erpes simplex virus (HSV) is a common human pathogen and a
significant source of morbidity (33). Severe disease and mortality are rare in most populations, occurring most frequently in immunocompromised individuals (24, 26). Those lacking Stat1 or having
interferon (IFN) signaling defects are among the most susceptible,
especially to central nervous system (CNS) infection (3, 7). IFN responses represent a critical early barrier to infection, and in common
with all viruses, HSV encodes a variety of functions that counter the
antiviral effects of IFN (18). One such function pertinent to this study
is virion host shutoff (vhs), encoded by the UL41 gene of HSV (25).
vhs is a tegument-derived endoribonuclease (13, 31) that is conserved
among neurotropic herpesviruses (2). Consistent with the ability of
vhs to destabilize a broad spectrum of mRNAs (30), vhs modulates
various aspects of the host immune response, including IFN responses, dendritic cell maturation, antigen presentation, and cytokine/chemokine elicitation (4, 6, 19, 32). Correspondingly, the replication and virulence of HSV strains lacking vhs is significantly
reduced in wild-type mice but significantly increased in mice lacking
IFN responses (1, 20, 23, 28). While vhs is critical for HSV replication
in vivo, its impact in cell culture varies greatly by cell type (5). The
growth deficits observed in certain cells were correlative with induction of stress granules (indicating stalled translation) and decreased
accumulation of viral late genes. These inherent in vitro growth defects were shown to be independent of IFN responses and consistent
with a cell type-specific growth deficit (5). In this study, we sought to
examine the role of vhs in promoting viral replication and virulence
in vivo in the absence of type 1 and type II IFN responses. Previous
studies of a vhs-deleted HSV-1 strain (UL41NHB [28], hereinafter
referred to as ⌬vhs) in Stat1⫺/⫺ mice showed incomplete restoration
of growth and virulence relative to those of a wild-type (KOS) virus
(23). While these Stat1⫺/⫺ mice were highly susceptible to HSV infection, they maintain some persistent IFN-dependent responses that
affect viral growth and pathogenesis (21), possibly explaining the incomplete restoration of growth and virulence to ⌬vhs. Testing ⌬vhs
in type I/II IFN receptor knockout mice (AG129) therefore affords
direct analysis of the role of IFN responses in controlling ⌬vhs replication and virulence and allows the examination of IFN-independent
defects of ⌬vhs replication in vivo.
To assess the extent to which the replication of ⌬vhs might be
inherently limited in an IFN-independent fashion in cells derived
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from AG129 mice, we compared the replication of ⌬vhs to that of
wild-type KOS using multistep growth analyses at a multiplicity of
infection (MOI) of 0.01 in bone marrow-derived dendritic cells
(BMDCs) from wild-type (strain 129) and AG129 mice as previously described (17). BMDCs are a challenging environment for
HSV replication, especially for viruses with engineered deletions
in virulence genes (8, 9). Consistent with this, the replication of
⌬vhs was significantly reduced (P ⬍ 0.0005 at 48 h) in wild-type
(strain 129/SvEv mice, Taconic Farms) BMDCs relative to the
replication of KOS in these cells (Fig. 1A and B). In AG129
BMDCs, both ⌬vhs and KOS virus showed significantly more replication (P ⬍ 0.005 at 48 h) than in wild-type BMDCs, but the
replication of ⌬vhs was not restored to the levels observed for KOS
(P ⬍ 0.002 at 48 h). This is in contrast to the restoration of ⌬vhs
replication observed in mouse embryonic fibroblasts (MEFs) derived from AG129 mice (22).
Previous in vivo work showed that vhs-deficient virus replication
was significantly reduced in the wild-type mouse cornea (27, 28), and
replication was only partially restored in mice lacking Stat1 (23). We
therefore wished to examine the replication of ⌬vhs in the corneas of
AG129 mice using methods previously described (28). Mice were
infected with 2 ⫻ 106 PFU per scarified eye of KOS or ⌬vhs, and
replication measured by eye swab assays from day 1 through 7 postinfection (Fig. 1C and D). The replication of both KOS and ⌬vhs was
significantly enhanced (P ⬍ 0.02 at 3 days) in AG129 mice relative to
that in wild-type mice, although the increased replication of ⌬vhs in
AG129 corneas was not restored to the levels observed for KOS in
these IFN-deficient mice. These data suggested that while IFN was
limiting to the replication of both viruses, the replication defect of
⌬vhs observed in both BMDCs and corneas was inherent to vhs deficiency and yet independent of IFN.
To further assess the impact of vhs on the tropism and pathogen-
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FIG 1 Replication of KOS and ⌬vhs in bone marrow-derived dendritic cells (BMDCs) and corneas of wild-type and IFN-deficient mice, and their virulence and
spread following corneal infection. (A) Multiple-step growth curve of KOS in BMDCs derived from either wild-type or AG129 mice. (B) Multiple-step growth
curve of ⌬vhs in BMDCs derived from either wild-type or AG129 mice. (C) Replication of KOS in scarified corneas of wild-type or AG129 mice following
inoculation of 2 ⫻ 106 PFU per eye. (D) Replication of ⌬vhs in scarified corneas of wild-type or AG129 mice following inoculation of 2 ⫻ 106 PFU per eye. No
corneal titers are shown for KOS in AG129 mice beyond day 5 due to mortality. (E) Tropism and spread of KOSdlux and ⌬vhsdlux shown by bioluminescence
imaging following corneal infection with 2 ⫻ 106 PFU per eye. Living mice were imaged daily by IVIS (Caliper Lifesciences) following anesthesia and injection
of 150 g/g D-luciferin. Images were formatted on an identical photon flux scale as 103 photons/s/sr/cm2. No images are shown for KOSdlux in AG129 mice
beyond day 4 due to mortality. Data shown are derived from or representative of at least 2 experiments.

esis of HSV-1 in AG129 mice, we performed bioluminescence imaging as previously described (14–16, 21). The viruses used were KOS/
dlux/oriL (29) (hereinafter referred to KOSdlux) and a new virus,
⌬vhsdlux, in which the firefly luciferase-expressing cassette described
previously for making KOSdlux was inserted into the UL49.5 locus
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(29) of the vhs-deficient mutant UL41NHB using homologous recombination (28). Following corneal infection with KOSdlux, as expected, the previously published pattern of bioluminescence was observed (15), with the appearance of light signals in cervical lymph
nodes by day 2 and increasingly strong signals in nodes and livers
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FIG 2 Survival of wild-type and AG129 mice following corneal or intracerebral (ic) challenge with KOS and ⌬vhs viruses. (A) Survival of AG129 mice following

corneal challenge with 2 ⫻ 106 PFU of either KOS or ⌬vhs. (B) Survival of AG129 mice following intracerebral challenge with 1 ⫻101 PFU or 1 ⫻ 102 PFU of either
KOS or ⌬vhs. Results are derived from at least 2 independent experiments for each panel.

from day 3 to day 4 (Fig. 1E). Mortality precluded imaging of the
KOSdlux-infected mice on and beyond day 5. Overall, ⌬vhsdlux
showed a tropism similar to that of KOSdlux in AG129 mice, but peak
signals in all tissues were delayed by 1 day and attenuated approximately 200-fold. Interestingly, the AG129 mice cleared the ⌬vhs visceral infection by day 7 (Fig. 1E and data not shown) and yet began to
show mortality at and beyond this time point (Fig. 2A). Taken together, these data demonstrate, both in vitro and in vivo, the strong
impact of IFN-independent defects on the replication of a vhs-deficient HSV-1 strain in BMDCs and peripheral tissues.
One possible explanation for these data is that the cornea serves as
an IFN-independent bottleneck to ⌬vhs infection and that, once
⌬vhs gains access to the CNS, it is able to replicate robustly and cause
mortality. To test this possibility further, we examined the virulence
and replication of KOS and ⌬vhs in the brain following corneal and
intracerebral infection, as previously described (28). Observation of
wild-type and AG129 mice infected via the cornea revealed a striking
difference in survival following infection with KOS or ⌬vhs. All wildtype mice survived infection with either virus (data not shown). KOSinfected AG129 mice (13/13) all died synchronously on day 5, while
the ⌬vhs-infected mice had a median survival of 11 days, with a more
gradual mortality (42/47) out to day 21 (Fig. 2A). Despite the significantly (P ⬍ 0.0001) longer survival time for ⌬vhs-infected mice, this
high degree of lethality was unexpected given the significant attenuation of ⌬vhs for corneal replication in these mice relative to the level
of replication of KOS (Fig. 1C and D). This also contrasted strongly
with ⌬vhs infection in corneas of Stat1⫺/⫺ mice in which ⬃90% of
mice survived to day 21 (20, 23). When wild-type mice were intracerebrally infected (28) with 2 ⫻ 106 PFU, KOS was significantly more
virulent (6% survival) than ⌬vhs (79% survival; data not shown) in
wild-type mice. In contrast, in AG129 mice, the virulence of ⌬vhs was
indistinguishable from that of KOS (P ⬎ 0.17), even following infection with only 1 ⫻ 101 or 1 ⫻ 102 PFU (Fig. 2B). To assess this further,
we examined virus replication in brain stems in wild-type and AG129
mice following corneal (2 ⫻ 106 PFU) or intracerebral (1 ⫻ 102 PFU)
infection with either KOS or ⌬vhs (Fig. 3). Both corneal and intracerebral infection of wild-type mice resulted in detectable titers (ⱕ8 ⫻
103 PFU) of KOS per brain stem, while ⌬vhs remained mostly undetectable (Fig. 3A and B). In AG129 mice following corneal infection,
KOS was readily detectable by day 3 in the brain stem and reached
⬎1 ⫻ 105 PFU per brain on day 5, when 100% mortality was seen
(Fig. 3C). Following corneal infection with ⌬vhs, increasing brain
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stem titers were observed on days 3 to 5, with titers of ⬎1 ⫻ 104 on
day 7, at which time the first mortality was observed (Fig. 2A). For all
data shown in Fig. 3B and C, the replication differences between KOS
and ⌬vhs were statistically significant (P values ranging from 0.017 to
7 ⫻ 10⫺7). Intracerebral infection of AG129 mice with 100 PFU of
KOS or ⌬vhs resulted in high (105 to 106 PFU/brain stem) titers on
days 3 and 5 (Fig. 3D). These titers were statistically indistinguishable
between KOS and ⌬vhs (P ⫽ 0.28) on day 3. Although significant
differences between these viruses were seen on day 5 (P ⫽ 0.002), the
10-fold difference in KOS and ⌬vhs titers in this tissue is in stark

FIG 3 Virus replication in brain stems in wild-type and AG129 mice following
corneal or intracerebral (ic) infection with either KOS or ⌬vhs viruses. “ND”
indicates virus not detected. (A) Brain stem titers following corneal infection
of wild-type mice with 2 ⫻ 106 PFU KOS or ⌬vhs per eye. (B) Brain stem titers
following intracerebral infection of wild-type mice with 2 ⫻ 102 PFU KOS or
⌬vhs. (C) Brain stem titers following corneal infection of AG129 mice with 2 ⫻
106 PFU KOS or ⌬vhs. KOS-infected AG129 mice died on day 5, precluding
corneal swab sampling on day 7. (D) Brain stem titers following intracerebral
infection of AG129 mice with 1 ⫻ 102 PFU KOS or ⌬vhs. Results are derived
from at least 2 independent experiments for each panel.
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contrast with the almost-100,000-fold difference observed in the
AG129 corneas at this time point. These data therefore show that in
AG129 mice, the virulence of ⌬vhs is attenuated by the corneal route
but largely restored by the intracerebral route.
Humans and experimental animal models show significant resistance to corneal infection by ocular pathogens, unless the cornea is
physically damaged or compromised through IFN deficiency (12).
This is also consistent with the observation that significant bottlenecks for the transition of poliovirus from the periphery to the nervous system include both physical and IFN-responsive barriers (11).
The attenuation of ⌬vhs in AG129 mice by the corneal route contrasts with significantly higher virulence by the intracerebral and intraperitoneal routes (data not shown), and these data together support the hypothesis that the cornea is a potent replication bottleneck
to ⌬vhs replication, even in the absence of IFN responses. Although
other tissues probably also limit the replication of vhs-deficient viruses (as evidenced by the lack of spread from the viscera by ⌬vhs),
the limitation in the cornea is especially pertinent since it is both a
common natural and experimental site of infection. This study also
provides an in vivo parallel to previous work (5) that showed that the
ability of vhs to augment HSV replication was highly cell-type dependent in vitro. Previous observations of the conservation of vhs among
neurotropic herpesviruses, the attenuation of vhs-deficient viruses in
the nervous system, and the role of vhs in evading the IFN response
have collectively suggested that vhs must be critical for the neuropathogenesis of HSV (2, 10, 20, 28). This study, however, suggests
that the inherent growth defect of vhs-deficient HSV-1 strains in the
periphery is a critical determinant of their attenuation.
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